Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

12 hours Eli Lilly (LLY) Vs Novo Nordisk (NVO): Which is the Best Weight Loss Stock for 2025? Zacks

Weight loss goals may be at the forefront of many New Year’s resolutions, which could push the exuberance for Eli Lilly (LLY) and Novo Nordisk (NVO) stock.

Eli Lilly (LLY)

  X     

21 hours Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly MarketWatch

   X     

24 hours LLY Falls Around 14% in 3 Months: How to Play the Stock Zacks

   X     

1 day Flynn: Eli Lilly could capture a significant part of a $100 billion market with Zepbound. YouTube

   X     

3 days Why the Market Dipped But Eli Lilly (LLY) Gained Today Zacks

   X     

4 days Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More Potential Seeking Alpha

   X     

7 days Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

1 week The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

2 weeks Why Eli Lilly (LLY) Dipped More Than Broader Market Today Zacks

   X     

2 weeks Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

   X     

2 weeks Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks

   X     

3 weeks Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance

   X     

3 weeks Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

3 weeks Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks

   X     

3 weeks Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance

   X     

3 weeks Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance

   X     

3 weeks Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance

   X     

3 weeks Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily

   X     

3 weeks Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance

   X     

3 weeks Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube

   X     

3 weeks Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com

   X     

3 weeks There’s a New Obesity King The Wall Street Journal

   X     

3 weeks Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha

   X     

3 weeks LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks

   X     

3 weeks FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com

   X     

3 weeks Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch

   X     

3 weeks Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com

   X     

3 weeks IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily

   X     

3 weeks FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC

   X     

3 weeks Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha

   X     

3 weeks Eli Lilly’s Alzheimer’s treatment approved in China Investing.com

   X     

3 weeks Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com

   X     

3 weeks Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks

   X     

3 weeks NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

   X     

3 weeks 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance

   X     

3 weeks Eli Lilly: A Rare Buying Opportunity Seeking Alpha

   X     

4 weeks Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily

   X     

4 weeks EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks

   X     

4 weeks Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com

   X     

4 weeks Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks

   X     

4 weeks Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025 Yahoo Finance

   X     

4 weeks Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

   X     

4 weeks Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly CNBC

   X     

1 month Eli Lilly to test obesity drugs to treat addiction in 2025, CEO says #shorts #weightloss #zepbound YouTube

   X     

1 month Eli Lilly to test obesity drugs for smoking, alcohol abuse – Bloomberg Investing.com

   X     

1 month Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose Investing.com

   X     

1 month Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15% Zacks

   X     

1 month The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

   X     

1 month Eli Lilly announces $15 billion buyback, dividend hike Investing.com

   X     

1 month Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

   X     

1 month Netflix, Eli Lilly among Monday’s market cap stock movers Investing.com

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News